Point72 Asset Management is a fund manager in Stamford with $138.46 bn assets under management.
Company profile
Website
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
IRS number
465064661
SEC advisor number
801-107348
FINRA CRD number
283077
AUM ?
$139.91 bn
(as of 5 May 23)
Accounts
18
(as of 5 May 23)
Employees
2,311
(1085 investment advisory or research)
Address
Point72 Asset Management
72 CUMMINGS POINT ROAD
STAMFORD
CT 06902
72 CUMMINGS POINT ROAD
STAMFORD
CT 06902
Phone
203-890-2000
Ownership
Fund structure | AUM | Fund type |
---|---|---|
POINT72 Asset Management, L.P. | $138.46 bn | |
CPV Holdings, LLC | $2.86 bn | Private Equity Fund |
CPV Real Estate Holdings, LLC | Real Estate Fund | |
Cubist Core Investments, LLC | $26.06 bn | Hedge Fund |
Cubist Strategic Investments, LLC | $437.39 mm | Hedge Fund |
Cubist Systematic Investments, LLC | Hedge Fund | |
POINT72 Associates, LLC | $45.39 bn | Hedge Fund |
POINT72 Capital International II, LTD. | $914.21 mm | Hedge Fund |
POINT72 Capital International, LTD. | $14.83 bn | Hedge Fund |
POINT72 Capital, L.P. | $8.19 bn | Hedge Fund |
POINT72 Employee Opportunities Fund, L.P. | $498.34 mm | Hedge Fund |
POINT72 Employee Opportunities Fund, LTD. | $428.72 mm | Hedge Fund |
POINT72 Family Fund, L.P. | $80.78 mm | Hedge Fund |
POINT72 Global Macro Investments, LLC | $65.38 bn | Hedge Fund |
POINT72 Hyperscale Investments, L.P. | $443.52 mm | Private Equity Fund |
POINT72 Hyperscale International, L.P. | $134.81 mm | Private Equity Fund |
POINT72 Hyperscale, L.P. | $120.85 mm | Private Equity Fund |
POINT72 Strategies, LLC | $34.82 mm | Hedge Fund |
Latest filings (excl ownership)
No filings
Latest ownership filings
SC 13G
Cogent Biosciences, Inc.
1 Jun 23
SC 13G
Elevation Oncology, Inc.
24 May 23
SC 13G
CUTERA INC
16 May 23
13F-HR
Quarterly holdings report by institutional manager
15 May 23
13F-HR/A
Quarterly holdings report by institutional manager (amended)
15 May 23
SC 13G
Esperion Therapeutics, Inc.
5 Apr 23
SC 13G/A
Cepton, Inc.
9 Mar 23
SC 13G
Inari Medical, Inc.
24 Feb 23
SC 13G
IOVANCE BIOTHERAPEUTICS, INC.
17 Feb 23
13F-HR
Quarterly holdings report by institutional manager
14 Feb 23